Great Point Partners, LLC 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:59 pm Sale | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Great Point Partners, LLC | 1,055,801 3.100% | -224,199 (-17.52%) | Filing |
| 2022-05-18 4:03 pm Purchase | 2022-05-09 | 13G | KalVista Pharmaceuticals, Inc. KALV | Great Point Partners, LLC | 1,280,000 5.220% | 1,280,000 (New Position) | Filing |